DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bevirimat
Bevirimat
Download Article PDF/Slides
Ep 2531027 B1
Synthesis and Development of Long-Acting Abacavir Prodrug Nanoformulations
Current Status and Prospects of HIV Treatment
Background Paper 6.7 Human Immunodeficiency Virus (HIV)/ Acquired Immune Deficiency Syndromes (AIDS)
Can the Further Clinical Development of Bevirimat Be Justified?
NRTI Toxicity Francois Venter Wits Reproductive Health & HIV Institute
Antiviral Drugs in the Treatment of Aids: What Is in the Pipeline ?
PATHOLOGY of HIV/AIDS 32Nd Edition
Repurposing of FDA Approved Drugs
NIH Public Access Author Manuscript Bioorg Med Chem Lett
TABLE 2. HIV Treatment Pipeline 2003–2012 Class Drug Name Generic Name Brand Name Sponsor 2003 2004 2005 2006 2007 2008 2009 2
The Prototype HIV-1 Maturation Inhibitor, Bevirimat, Binds to the CA
Drug Resistance of Human Immunodeficiency Virus and Overcoming It by Natural Products
Novel Antiretroviral Agents
Chemical Diversity and Activity Profiles of HIV-1 Reverse Transcriptase
WO 2013/116720 Al 8 August 2013 (08.08.2013) P O P C T
Efficacy of Antiretroviral Compounds Against Toxoplasma Gondii in Vitro
Top View
NIH Public Access Author Manuscript J Med Chem
Clinical Protocol AI468048
HIV-1 Protease Inhibitor Mutations Affect the Development of HIV-1
HIV/AIDS Research at the NCI:A Record of Sustained Excellence
Ositive Ulse
Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-Hu Thy/Liv Mice Cheryl A
Review Novel Compounds for the Treatment of HIV Type-1 Infection
Natural Products with Inhibitory Activity Against Human Immunodeficiency Virus Type 1
Insight Into the Mechanism of Action of EP-39, A
TAG 2009 Pipeline Report
Report on the XVII International HIV Drug Resistance Workshop
Medical Management of HIV Infection Bartlett.Pdf
Screening of Natural Products for Anti-HIV Potential: an in Vitro Approach
Drug Interactions with New and Investigational Antiretrovirals
The Outlook for a Cure There Is a Formidable Arsenal of Drugs Available to Treat HIV
The Structural Biology of HIV-1: Mechanistic and Therapeutic Insights
Recent Advances in Antiretroviral Treatment and Prevention in HIV-|Níectedpatients
CROI 2013: New Drugs for Treatment and Prep
Identification of Novel Compounds Against Three Targets of SARS Cov-2 Coronavirus by Combined Virtual Screening and Supervised Machine Learning
Absence of Naturally Existing Resistance Against the HIV-1 Capsid # PE 13/22 Inhibitor GS-6207 in HIV-1 Primary Isolates Gilead Sciences, Inc
Macrophage-Targeted Nanocarriers for Anti-HIV Therapy
The State of Hiv Treatment
2011 Pipeline Report Second Edition
Insight Into the Mechanism of Action of EP-39, a Bevirimat Derivative That Inhibits HIV-1 Maturation T